Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (629 total)
-
Créateur: Wu, Zhiwei, Yaling Hu, Miao Xu, Zhen Chen, Wanqi Yang, Zhiwei Jiang, Minjie Li, Hui Jin, Guoliang Cui, Panpan Chen, Lei Wang, Guoqing Zhao, Yuzhu Ding, Yuliang Zhao, and Weidong Yin.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-03
Description: A vaccine against COVID-19 is urgently needed for older adults, in whom morbidity and mortality due to the disease are increased. We aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing… -
Créateur: Wu, Kai, Anne P. Werner, Matthew Koch, Angela Choi, Elisabeth Narayanan, Guillaume B. E. Stewart-Jones, Tonya Colpitts, Hamilton Bennett, Seyhan Boyoglu-Barnum, Wei Shi, Juan I. Moliva, Nancy J. Sullivan, Barney S. Graham, Andrea Carfi, Kizzmekia S.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-17
Description: The mRNA-1273 vaccine against SARS-CoV-2 elicited high neutralizing-antibody titers in phase 1 trial participants and has been shown to be highly efficacious in preventing symptomatic Covid-19 disease and severe disease. -
Créateur: Wright, David J. M.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-05-07
Description: The Comment by Marc Feldman and colleagues,1 published recently in The Lancet, discussed the potential of anti-tumor necrosis factor (TNF) therapy to inhibit development of a cytokine storm in patients with coronavirus disease 2019 (COVID-19).… -
Créateur: Wood, Simon N., Ernst C. Wit, Matteo Fasiolo, and Peter J. Green.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-05-28
Description: Knowing the infection fatality ratio (IFR) is crucial for epidemic management: for immediate planning, for balancing the life-years saved against those lost to the consequences of management, and for considering the ethics of paying substantially… -
Créateur: Wongvibulsin, Shannon, Brian T. Garibaldi, Annukka A. R. Antar, Jiyang Wen, Mei-Cheng Wang, Amita Gupta, Robert Bollinger, Yanxun Xu, Kunbo Wang, Joshua F. Betz, John Muschelli, Karen Bandeen-Roche, Scott L. Zeger, and Matthew L. Robinson.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-02
Description: Predicting the clinical trajectory of individual patients hospitalized with coronavirus disease 2019 (COVID-19) is challenging but necessary to inform clinical care. The majority of COVID-19 prognostic tools use only data present upon admission and… -
Créateur: Woloshin, Steven, Neeraj Patel, and Aaron S. Kesselheim.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-06-05
Description: There is broad consensus that widespread SARS-CoV-2 testing is essential to safely reopening the United States. A big concern has been test availability, but test accuracy may prove a larger long-term problem. -
Créateur: Winter, Amy K., and Sonia T. Hegde.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-21
Description: As of April 14, 2020, just under 2 million cases of coronavirus disease 2019 (COVID-19) have been reported worldwide. -
Créateur: Wiley, Z., K. Ross-Driscoll, Z. Wang, L. Smothers, A. K. Mehta, and R. E. Patzer.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-02
Description: Since the introduction of remdesivir and dexamethasone for severe COVID-19 treatment, few large multi-hospital system US studies have described clinical characteristics and outcomes of minority COVID-19 patients who present to the emergency… -
Créateur: Wilder-Smith, Annelies, Calvin J. Chiew, and Vernon J. Lee.
Sujet: Infection Control
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-05
Description: The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. -
Créateur: WHO Solidarity Trial Consortium
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-02
Description: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19).